Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial
Ter Maaten, J. M., Beldhuis, I. E., van der Meer, P., Krikken, J. A., Postmus, D., Coster, J. E., Nieuwland, W., van Veldhuisen, D. J., Voors, A. A. & Damman, K., 28-Aug-2023, (E-pub ahead of print) In: Nature Medicine. 23 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Trajectories of renal biomarkers and new-onset heart failure in the general population: Findings from the PREVEND study
Sakaniwa, R., Tromp, J., Streng, K. W., Suthahar, N., Kieneker, L. M., Postmus, D., Iso, H., Gansevoort, R. T., Bakker, S. J. L., Hillege, H. L., de Boer, R. A. & Demissei, B. G., Jul-2023, In: European Journal of Heart Failure. 25, 7, p. 1072-1079 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)4 Downloads (Pure) -
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study
Roldan Munoz, S., Postmus, D., de Vries, S. T., Gross-Martirosyan, L., Bahri, P., Hillege, H. & Mol, P. G. M., Mar-2023, In: Drug Safety. 46, 3, p. 243-255 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Downloads (Pure) -
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
DAPA-CKD Trial Committees and Investigators, Heerspink, H. J. L., Cherney, D., Postmus, D., Stefánsson, B. V., Chertow, G. M., Dwyer, J. P., Greene, T., Kosiborod, M., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, P., Sjöström, C. D., Toto, R. D. & Wheeler, D. C., Jan-2022, In: Kidney International. 101, 1, p. 174-184 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile41 Citations (Scopus)21 Downloads (Pure) -
A simulated maximum likelihood procedure for analyzing imprecise trade-off thresholds between the benefits and harms of medicines
Postmus, D., Pignatti, F., Hillege, H. L. & Tervonen, T., 20-Dec-2022, In: Statistics in Medicine. 41, 29, p. 5612-5621 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile12 Downloads (Pure)
Activities
- 1 Professional or public presentation
-
Quantitative Benefit-Risk Assessment
Hans Hillege (Speaker) & Douwe Postmus (Speaker)
26-Aug-2018Activity: Talk and presentation › Professional or public presentation › Professional
Press/Media
-
Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial
03/11/2021
1 item of Media coverage
Press/Media: Expert Comment › Popular